CEACAM5 and lung carcinoma: In vitro, NILK-2401 binds dose-dependently to colorectal (3/3), gastric (2/2) and lung carcinoma (2/2) cell lines with different CEACAM5 expression levels (Figure 2, Supplementary Table S1).